Role of autophagy in LPS‑induced inflammation in INS‑1 cells

Zhu,Li‑Bo; Cao,Ming‑Ming; Wang,Jun; Su,Ying; Jiang,Wei; Liu,Guo‑Dong; Li,Yan‑Bo

doi:10.3892/mmr.2019.10172

Role of autophagy in LPS‑induced inflammation in INS‑1 cells

Authors:
- Li‑Bo Zhu
- Ming‑Ming Cao
- Jun Wang
- Ying Su
- Wei Jiang
- Guo‑Dong Liu
- Yan‑Bo Li
View Affiliations

Affiliations: Department of Endocrinology, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China
Published online on: April 19, 2019 https://doi.org/10.3892/mmr.2019.10172
Pages: 5211-5218

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Inflammation has been implicated in the pathogenesis of type 2 diabetes (T2D), which is a progressive disease characterized by pancreatic β‑cell dysfunction and apoptosis with consequential insufficient insulin secretion. Autophagy is necessary to maintain the structure, mass and function of pancreatic β‑cells. The present study investigated the crosstalk between autophagy and inflammasome activation in T2D. INS‑1 cells were stimulated with lipopolysaccharide. Apoptosis and reactive oxygen species (ROS) formation were measured using flow cytometry, and cell proliferation was measured using Cell Counting Kit‑8 solution. Autophagy was assayed using western blotting and transmission electron microscopy. The expression levels of interleukin‑1β (IL‑1β) and caspase‑1 were detected by western blotting. The results demonstrated that inhibiting autophagy using 3‑methyladenine (3‑MA) promoted INS‑1 cell apoptosis. This response was correlated with an increase in ROS production and the inflammatory response, including IL‑1β maturation and caspase‑1 activation. Furthermore, when ROS were inhibited using N‑acetyl‑L‑cysteine, inflammation was decreased. These results demonstrated that inhibition of autophagy enhanced inflammatory injury via the ROS‑mediated activation of the Nod‑like receptor pyrin domain‑containing protein 3 inflammasome. Autophagy may have a protective effect by mitigating inflammation in T2D, which may provide a novel approach for T2D treatment.

View Figures

View References

1	Donath MY and Shoelson SE: Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 11:98–107. 2011. View Article : Google Scholar : PubMed/NCBI
2	Eguchi K and Manabe I: Macrophages and islet inflammation in type 2 diabetes. Diabetes Obes Metab. 3 (Suppl 15):S152–S158. 2013. View Article : Google Scholar
3	Yang CM, Shin DM and Jo EK: The role of NLR-related protein3 inflammasome in host defense and inflammatory diseases. Int Neurourol J. 16:2–12. 2012. View Article : Google Scholar : PubMed/NCBI
4	Masini M, Bugliani M, Lupi R, del Guerra S, Boggi U, Filipponi F, Marselli L, Masiello P and Marchetti P: Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia. 52:1083–1086. 2009. View Article : Google Scholar : PubMed/NCBI
5	Gomes LC, Di Benedetto G and Scorrano L: During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol. 13:589–598. 2011. View Article : Google Scholar : PubMed/NCBI
6	Goldman SJ, Taylor R, Zhang Y and Jin S: Autophagy and the degradation of mitochondria. Mitochondrion. 10:309–315. 2010. View Article : Google Scholar : PubMed/NCBI
7	Lee J, Giordano S and Zhang J: Autophagy, mitochondria and oxidative stress: Cross-talk and redox signalling. Biochem J. 441:523–540. 2012. View Article : Google Scholar : PubMed/NCBI
8	Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, et al: Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 27:433–446. 2008. View Article : Google Scholar : PubMed/NCBI
9	Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS and Lwasaki A: Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci USA. 106:2770–2775. 2009. View Article : Google Scholar : PubMed/NCBI
10	Petersen KF, Dufour S, Befroy D, Garcia R and Shulman GI: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Eng J Med. 350:664–671. 2004. View Article : Google Scholar
11	Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, et al: Activation of the Nlrp3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol. 11:897–904. 2010. View Article : Google Scholar : PubMed/NCBI
12	Jing Yin J, Bo Li Y, Ming Cao M and Wang Y: Liraglutide improves the survival of INS-1 cells by promoting macroau-tophagy. Int J Endocrinol Metab. 11:184–190. 2013. View Article : Google Scholar : PubMed/NCBI
13	Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ and Ting JP: Fatty acid-induced NLRP3ASC inflammasome activation interferes with insulin signaling. Nat Immunol. 12:408–415. 2011. View Article : Google Scholar : PubMed/NCBI
14	Chan JY, Cooney GJ, Biden TJ and Laybutt DR: Differential regulation of adaptive and apoptotic unfolded protein response signalling by cytokine-induced nitric oxide production in mouse pancreatic beta cells. Diabetologia. 54:1766–1776. 2011. View Article : Google Scholar : PubMed/NCBI
15	Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al: Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 56:1761–1772. 2007. View Article : Google Scholar : PubMed/NCBI
16	Van der Crabben SN, Blümer RM, Stegenga ME, Ackermans MT, Endert E, Tanck MW, Serlie MJ, van der Poll T and Sauerwein HP: Early endotoxemia increases peripheral and hepatic insulin sensitivity in healthy humans. J Clin Endocrinol Metab. 94:463–468. 2009. View Article : Google Scholar : PubMed/NCBI
17	Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
18	Choi SE, Lee SM, Lee YJ, Li LJ, Lee SJ, Lee JH, Kim Y, Jun HS, Lee KW and Kang Y: Protective role of autophagy in palmitate-induced INS-1 beta-cell death. Endocrinology. 150:126–134. 2009. View Article : Google Scholar : PubMed/NCBI
19	Xia G, Zhu T, Li X, Jin Y, Zhou J and Xiao J: ROS-mediated autophagy through the AMPK signaling pathway protects INS-1 cells from human islet amyloid polypeptide-induced cytotoxicity. Mol Med Rep. 18:2744–2752. 2018.PubMed/NCBI
20	Ashcroft FM, Rohm M, Clark A and Brereton MF: Is type 2 diabetes a glycogen storage disease of pancreatic β Cells? Cell Metab. 26:17–23. 2017. View Article : Google Scholar : PubMed/NCBI
21	Böni-Schnetzler M, Thorne J, Parnaud G, Marselli L, Ehses JA, Kerr-Conte J, Pattou F, Halban PA, Weir GC and Donath MY: Increased interleukin (IL)-1β messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab. 93:4065–4074. 2008. View Article : Google Scholar : PubMed/NCBI
22	Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA and Donath MY: Glucose-induced beta-cell production of interleukin-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest. 110:851–860. 2002. View Article : Google Scholar : PubMed/NCBI
23	Ribaux P, Ehses JA, Lin-Marq N, Carrozzino F, Böni-Schnetzler M, Hammar E, Irminger JC, Donath MY and Halban PA: Induction of CXCL1 by extracellular matrix and autocrine enhancement by interleukin-1 in rat pancreatic beta-cells. Endocrinology. 148:5582–5590. 2007. View Article : Google Scholar : PubMed/NCBI
24	Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M and Nielsen JH: Affinity-purified human interleukin I is cytotoxic to isolated islets of langerhans. Diabetologia. 29:63–67. 1986. View Article : Google Scholar : PubMed/NCBI
25	Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A and Ehses JA: Islet inflammation in Type 2 diabetes: from metabolic stress to therapy. Diabetes Care. 2 (Suppl 31):S161–S164. 2008. View Article : Google Scholar
26	Schroder K and Tschopp J: The inflammasomes. Cell. 140:821–832. 2010. View Article : Google Scholar : PubMed/NCBI
27	Zhao G, Dharmadhikari G, Maedler K and Meyer-Hermann M: Possible role of interleukin-1β in type 2 diabetes onset and implications for anti-inflammatory therapy strategies. PLoS Comput Biol. 10:e10037982014. View Article : Google Scholar : PubMed/NCBI
28	Maedler K, Schumann DM, Sauter N, Ellingsgaard H, Bosco D, Baertschiger R, Iwakura Y, Oberholzer J, Wollheim CB, Gauthier BR and Donath MY: Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated β-cell proliferation in human pancreatic islets. Diabetes. 55:2713–2722. 2006. View Article : Google Scholar : PubMed/NCBI
29	Green DR, Galluzzi L and Kroemer G: Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science. 333:1109–1112. 2011. View Article : Google Scholar : PubMed/NCBI
30	Singh R and Cuervo AM: Autophagy in the cellular energetic balance. Cell Metab. 13:495–504. 2011. View Article : Google Scholar : PubMed/NCBI
31	Kroemer G and Levine B: Autophagic cell death: The story of a misnomer. Nat Rev Mol Cell Biol. 9:1004–1010. 2008. View Article : Google Scholar : PubMed/NCBI
32	Zhou R, Tardivel A, Thorens B, Choi I and Tschopp J: Thioredoxin-in-teracting protein links oxidative stress to inflammasome activation. Nat Immunol. 11:136–140. 2010. View Article : Google Scholar : PubMed/NCBI
33	Lohitesh K, Saini H, Srivastava A, Mukherjee S, Roy A and Chowdhury R: Autophagy inhibition potentiates SAHA-mediated apoptosis in glioblastoma cells by accumulation of damaged mitochondria. Oncol Rep. 39:2787–2796. 2018.PubMed/NCBI